Cardiorenal Interactions. Insights From the ESCAPE Trial

Journal of the American College of Cardiology

Volumn 51, Issue 13, 2008, Pages 1268-1274

  Nohria, Anju ^a   Hasselblad, Vic ^b   Stebbins, Amanda ^b   Pauly, Daniel F ^c   Fonarow, Gregg C ^d   Shah, Monica ^b   Yancy, Clyde W ^e   Califf, Robert M ^b   Stevenson, Lynne W ^a   Hill, James A ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INOTROPIC AGENT; LOOP DIURETIC AGENT; THIAZIDE DIURETIC AGENT; VASODILATOR AGENT;

ARTICLE; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DISEASE COURSE; GLOMERULUS FILTRATION RATE; HEMODYNAMICS; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PULMONARY ARTERY CATHETER;

ACUTE DISEASE; CATHETERIZATION, SWAN-GANZ; CREATININE; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; HEART FAILURE; HEMODYNAMICS; HOSPITALIZATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 40849111905     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.08.072     Document Type: Article

References (21)

1. Hillege H.L., Girbes A.R., de Kam P.J., et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 102 (2000) 203-210
2. Dries D.L., Exner D.V., Domanski M.J., Greenberg B., and Stevenson L.W. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol 35 (2000) 681-689
3. Smilde T.D., Hillege H.L., Navis G., Boomsma F., de Zeeuw D., and van Veldhuisen D.J. Impaired renal function in patients with ischemic and nonischemic chronic heart failure: association with neurohormonal activation and survival. Am Heart J 148 (2004) 165-172
4. Krumholz H.M., Chen Y.T., Vaccarino V., et al. Correlates and impact on outcomes of worsening renal function in patients > or = 65 years of age with heart failure. Am J Cardiol 85 (2000) 1110-1113
5. Gottlieb S.S., Abraham W., Butler J., et al. The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Card Fail 8 (2002) 136-141
6. Shah M.R., O'Connor C.M., Sopko G., Hasselblad V., Califf R.M., and Stevenson L.W. Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE): design and rationale. Am Heart J 141 (2001) 528-535
7. Binanay C., Califf R.M., Hasselblad V., et al. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA 294 (2005) 1625-1633
8. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., and Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 (1999) 461-470
9. O'Meara E., Chong K.S., Gardner R.S., Jardine A.G., Neilly J.B., and McDonagh T.A. The Modification of Diet in Renal Disease (MDRD) equations provide valid estimations of glomerular filtration rates in patients with advanced heart failure. Eur J Heart Fail 8 (2006) 63-67
10. Shlipak M.G., Smith G.L., Rathore S.S., Massie B.M., and Krumholz H.M. Renal function, digoxin therapy, and heart failure outcomes: evidence from the digoxin intervention group trial. J Am Soc Nephrol 15 (2004) 2195-2203
11. McAlister F.A., Ezekowitz J., Tonelli M., and Armstrong P.W. Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation 109 (2004) 1004-1009
12. Hillege H.L., Nitsch D., Pfeffer M.A., et al. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 113 (2006) 671-678
13. Weinfeld M.S., Chertow G.M., and Stevenson L.W. Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure. Am Heart J 138 (1999) 285-290
14. Forman D.E., Butler J., Wang Y., et al. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol 43 (2004) 61-67
15. Butler J., Forman D.E., Abraham W.T., et al. Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J 147 (2004) 331-338
16. Parfrey P.S., and Foley R.N. The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol 10 (1999) 1606-1615
17. Heywood J.T. The cardiorenal syndrome: lessons from the ADHERE database and treatment options. Heart Fail Rev 9 (2004) 195-201
18. Palmer B.F. Renal dysfunction complicating the treatment of hypertension. N Engl J Med 347 (2002) 1256-1261
19. Persson P.B. Renal blood flow autoregulation in blood pressure control. Curr Opin Nephrol Hypertens 11 (2002) 67-72
20. Filler G., Bokenkamp A., Hofmann W., Le Bricon T., Martinez-Bru C., and Grubb A. Cystatin C as a marker of GFR-history, indications, and future research. Clin Biochem 38 (2005) 1-8
21. Shah M.R., Flavell C.M., Weintraub J.R., et al. Intensity and focus of heart failure disease management after hospital discharge. Am Heart J 149 (2005) 715-721